Maxcyte (MXCT) EBIT Margin Growth (1y) (2021 - 2026)
Maxcyte (MXCT) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 241.00 |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn | -1,908.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,908.00 |
| Dec 31, 2025 | 44,846.00 |
| Sep 30, 2025 | -3,506.00 |
| Jun 30, 2025 | 7,386.00 |
| Mar 31, 2025 | 10,149.00 |
| Dec 31, 2024 | -18,257.00 |
| Sep 30, 2024 | 16,357.00 |
| Jun 30, 2024 | -9,653.00 |
| Mar 31, 2024 | 4,565.00 |
| Dec 31, 2023 | 5,654.00 |
| Sep 30, 2023 | -26,324.00 |
| Jun 30, 2023 | -5,361.00 |
| Mar 31, 2023 | -22,958.00 |
| Dec 31, 2022 | -2,101.00 |
| Sep 30, 2022 | -4,837.00 |
| Jun 30, 2022 | -2,881.00 |
| Mar 31, 2022 | 11,445.00 |
| Dec 31, 2021 | -1,972.00 |
| Sep 30, 2021 | 3,678.00 |
| Jun 30, 2021 | 6,014.00 |